David H. Avery, M.D.; Keith E. Isenberg, M.D.;
Shirlene M. Sampson, M.D.; Philip G. Janicak, M.D.; Sarah H. Lisanby, M.D.; Daniel F. Maixner, M.D.; Colleen Loo, M.D.; Michael E. Thase, M.D.; Mark A. Demitrack, M.D.; and Mark S. George, M.D.
This report describes the results of an open-label extension study of active transcranial magnetic stimulation (TMS) in medication-resistant patients with major depressive disorder who did not benefit from an initial course of therapy in a previously reported 6-week, randomized controlled study of active versus sham TMS.